ERBB2 and neoplasm: Diffusion-weighted imaging (DWI) measures tumor cellularity as apparent diffusion coefficient (ADC) measurements, where rises in post-therapy cellularity (20–31% increases) signify the loci of cell lysis, and changes correspond to pCR in 80–85% of HER2-positive tumors [62,63].